NYSE$TFX
Teleflex Inc · Q1 2021 earnings
Q1 2021 earnings · · Investor relations
Briefing
Teleflex's Q1 2021 revenues increased slightly, with adjusted EPS exceeding expectations, but GAAP EPS decreased due to various adjustments.
Teleflex reported a slight increase in revenue for Q1 2021, driven by strong performance in the Americas and Asia. Adjusted EPS exceeded expectations due to higher gross and operating margins. The company raised its full-year revenue and adjusted EPS guidance.
- Q1 2021 revenues increased by 0.5% year-over-year to $633.9 million.
- GAAP diluted EPS from continuing operations decreased 43.2% to $1.58.
- Adjusted diluted EPS from continuing operations increased 5.5% to $2.87.
- Full year 2021 revenue and adjusted EPS guidance raised.
Headline financials
Revenue & EPS history
Teleflex · Revenue · Quarterly
$634M
Revenue by segment
Teleflex · $376M total across 1 segment · Q1 2021
- Americas Segment$376M+4.9%100.0%
Forward guidance
Teleflex raised its full year 2021 GAAP revenue growth estimates from a range of between 10.0% and 11.5% over 2020, to a range of between 10.50% and 11.75% over 2020, reflecting our estimate of an approximately 2% favorable impact of foreign currency exchange rate fluctuations. On a constant currency basis, the Company raised its full year 2021 revenue growth estimates from a range of between 8.0% and 9.5% over 2020, to a range of between 8.50% and 9.75% over 2020. The Company lowered its full year 2021 GAAP diluted earnings per share from continuing operations from a range of between $8.15 and $8.25 to a range of between $8.00 and $8.10. The Company raised its full year 2021 adjusted diluted earnings per share from continuing operations from a range of between $12.50 and $12.70 to a range of between $12.65 and $12.85.
Tailwinds
- Full year 2021 GAAP revenue growth estimates raised to a range of between 10.50% and 11.75%.
- Full year 2021 constant currency revenue growth estimates raised to a range of between 8.50% and 9.75%.
- Full year 2021 revenue growth estimate of 30% associated with its Interventional Urology business reaffirmed.
- Full year 2021 adjusted diluted earnings per share from continuing operations raised to a range of between $12.65 and $12.85.
- Forecasted 2021 GAAP revenue growth: 10.50%-11.75%
Headwinds
- Full year 2021 GAAP diluted earnings per share from continuing operations lowered from a range of between $8.15 and $8.25 to a range of between $8.00 and $8.10.
- Adverse economic conditions associated with the COVID-19 global health pandemic and the associated financial crisis.
- Changes in business relationships with and purchases by or from major customers or suppliers.
- Delays or cancellations in shipments.
- Demand for and market acceptance of new and existing products.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q1 2021
-0.4%
Avg return
Earnings day
-2.6%
Avg return
5 days after
-1.9%
Avg return
30 days after
53%
36 / 68 earnings
Positive
+12.5%
Q3 2023
Best reaction
-21.7%
Q4 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +6.9% | +4.6% | +5.2% | |
| Q4 2025 | +6.5% | +9.2% | +3.9% | |
| Q3 2025 | -13.3% | -10.0% | -3.4% | |
| Q1 2025 | -8.2% | -12.0% | -10.8% | |
| Q4 2024 | -21.7% | -26.4% | -22.4% | |
| Q3 2024 | -10.2% | -13.5% | -18.0% | |
| Q2 2024 | +7.3% | +4.5% | +11.0% | |
| Q1 2024 | -4.0% | -4.7% | -1.2% | |
| Q4 2023 | -5.3% | -9.9% | -12.0% | |
| Q3 2023 | +12.5% | +9.2% | +21.4% | |
| Q2 2023 | -4.3% | -7.6% | -14.1% | |
| Q1 2023 | -5.2% | -7.4% | -13.1% | |
| Q4 2022 | -2.3% | -1.0% | +3.4% | |
| Q3 2022 | +3.1% | +5.6% | +8.6% | |
| Q2 2022 | -9.8% | -5.9% | -15.9% | |
| Q1 2022 | -9.7% | -9.9% | -8.3% | |
| Q4 2021 | +6.4% | +3.4% | +5.3% | |
| Q3 2021 | -2.5% | +0.9% | -16.7% | |
| Q2 2021 | -0.5% | -3.6% | -2.8% | |
| Q1 2021 | -4.8% | -7.0% | -9.4% | |
| Q4 2020 | -0.6% | +0.8% | +3.2% | |
| Q3 2020 | -5.0% | -0.8% | +10.8% | |
| Q2 2020 | -7.0% | -8.2% | -4.0% | |
| Q1 2020 | -6.7% | -3.5% | +2.8% | |
| Q4 2019 | -6.3% | -11.9% | -38.3% | |
| Q3 2019 | +4.9% | +1.9% | +7.1% | |
| Q2 2019 | +6.4% | +6.8% | +7.1% | |
| Q1 2019 | +7.0% | +4.9% | +2.7% | |
| Q4 2018 | -0.4% | +0.7% | +5.3% | |
| Q3 2018 | +6.4% | +6.9% | +14.4% | |
| Q2 2018 | -9.2% | -12.4% | -8.6% | |
| Q1 2018 | +0.6% | -0.7% | -0.2% | |
| Q4 2017 | -5.5% | -6.0% | -6.3% | |
| Q3 2017 | +6.1% | +7.7% | +9.9% | |
| Q2 2017 | +5.5% | +4.9% | +3.7% | |
| Q1 2017 | -4.4% | -7.2% | -1.2% | |
| Q4 2016 | +3.1% | +3.9% | +5.9% | |
| Q3 2016 | -9.7% | -11.2% | -2.7% | |
| Q2 2016 | +3.2% | +3.0% | +4.4% | |
| Q1 2016 | -2.8% | — | — | |
| Q4 2015 | +9.6% | — | — | |
| Q3 2015 | +2.4% | — | — | |
| Q2 2015 | -4.5% | — | — | |
| Q1 2015 | +0.6% | — | — | |
| Q4 2014 | +4.6% | — | — | |
| Q3 2014 | +0.7% | — | — | |
| Q2 2014 | +1.9% | — | — | |
| Q1 2014 | +1.6% | — | — | |
| Q4 2013 | +3.0% | — | — | |
| Q3 2013 | +5.5% | — | — | |
| Q2 2013 | +0.2% | — | — | |
| Q1 2013 | -5.9% | — | — | |
| Q4 2010 | -0.4% | — | — | |
| Q4 2012 | +1.0% | — | — | |
| Q3 2012 | +3.7% | — | — | |
| Q2 2012 | +4.4% | — | — | |
| Q1 2012 | +0.9% | — | — | |
| Q4 2011 | +0.9% | — | — | |
| Q3 2011 | -1.2% | — | — | |
| Q2 2011 | +0.9% | — | — | |
| Q1 2010 | +2.9% | — | — | |
| Q1 2011 | +0.7% | — | — | |
| Q4 2008 | -2.6% | — | — | |
| Q3 2009 | -3.4% | — | — | |
| Q3 2010 | -3.4% | — | — | |
| Q2 2009 | +7.3% | — | — | |
| Q4 2009 | +7.3% | — | — | |
| Q2 2010 | +7.3% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro